Enfusion Inc (NYSE:ENFN)
$ 8.935 -0.015 (-0.17%) Market Cap: 821.23 Mil Enterprise Value: 805.63 Mil PE Ratio: 297.83 PB Ratio: 13.75 GF Score: 47/100

Q4 2023 Enfusion Inc Earnings Call Transcript

Mar 12, 2024 / 12:30PM GMT
Release Date Price: $9.36 (+9.86%)
Operator

Good morning, ladies and gentlemen. Thank you for standing by, and welcome to Enfusions Fourth Quarter and Full Year 2023 earnings conference call. (Operator Instructions)

As a reminder, this conference call is being recorded. I'd now like to turn the call over to Bill Wright, Head of Investor Relations, to begin.

Bill Wright
Enfusion, Inc. - Head of IR

Good morning, and thank you, operator. We welcome you to Enfusions Fourth Quarter and Full Year 2023 earnings conference call. Hosting today's call are Oleg Movchan, Enfusion's Chief Executive Officer; Brad Herring, Fusion's Chief Financial Officer, and Neal Pawar, Enfusions' newly appointed Chief Operating Officer.

Please note our quarterly shareholder letter, which includes our quarterly financial results, has been posted to our Investor Relations website. I would like to remind you that today's call may contain forward looking statements. These forward-looking statements are subject to numerous risks and uncertainties, including those set forth in our filings with the SEC which are

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot